Common Contracts
7 similar Rights Agreement contracts by Akebia Therapeutics, Inc., Tyra Biosciences, Inc.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTRights Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 5th day of March, 2021, by and among Tyra Biosciences, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
EX-4.2 4 d734398dex42.htm EX-4.2 Execution Version BEAM THERAPEUTICS INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT NOVEMBER 8, 2018 Page -i- Schedule A - Schedule of Investors Exhibit A - Form of Noncompetition and Nonsolicitation Agreement...Rights Agreement • May 5th, 2020 • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 8th day of November, 2018, by and among Beam Therapeutics Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
EX-4.2 6 d431688dex42.htm EX-4.2 Execution Version Allena Pharmaceuticals, Inc. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT Page - i - Schedule A – Schedule of Investors - ii - SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTRights Agreement • May 5th, 2020 • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 25th day of November, 2015 by and among Allena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto (together with any subsequent investors, or transferees, who become parties hereto as “Investors” pursuant to Section 6.9 below, the “Investors”).
EX-4.2 4 d734398dex42.htm EX-4.2 Execution Version BEAM THERAPEUTICS INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT NOVEMBER 8, 2018 Page -i- Schedule A - Schedule of Investors Exhibit A - Form of Noncompetition and Nonsolicitation Agreement...Rights Agreement • May 5th, 2020 • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 8th day of November, 2018, by and among Beam Therapeutics Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
EXECUTION VERSION INVESTORS’ RIGHTS AGREEMENT Page Schedule A - Schedule of Investors INVESTORS’ RIGHTS AGREEMENTRights Agreement • May 5th, 2020 • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 17th day of September, 2019, by and among 89bio, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any additional purchaser that becomes a party to this Agreement in accordance with Section 6.9 hereof.
EX-4 4 filename4.htm EXECUTION VERSION ACACIA COMMUNICATIONS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT April 17, 2013 Page Schedule A - Schedule of Investors AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTRights Agreement • May 5th, 2020 • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 17th day of April, 2013 by and among Acacia Communications, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto (each of which individually is referred to in this Agreement as an “Investor” and collectively as the “Investors”).
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTRights Agreement • March 4th, 2014 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the [—] day of February, 2014 by and among AKEBIA THERAPEUTICS, INC., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and collectively, the “Investors”), and any Additional Investor that becomes a party to this Agreement in accordance with Section 6.9 hereof.
